FSTL1 is upregulated in many solid tumor cells including glioma, gastric cancer, and hepatocellular carcinoma, and inhibiting the expression of FSTL1 can effectively reduce various malignant biological behaviors of cancer cells [30–32]. Here, FSTL1 is linked to hepatocellular carcinoma.